Life Sciences

The need for alignment to achieve health outcomes for all

As populations age and chronic diseases become commonplace, health care will take an ever larger share of GDP. Scientific progress, augmented intelligence and a more empowered patient are driving changes in the delivery of health care to a personalized experience that demands health outcomes as the core metric. This is causing a power shift among traditional stakeholder groups, with new entrants (often not driven by profit) disrupting incumbents.

Innovation, productivity and access to patients remain the industry’s biggest challenges. These trends challenge the capital strategy of every link in the life sciences value chain, from R&D and product supply to product launch and patient-centric operating models.

Our Global Life Sciences Sector brings together a worldwide network of 11,000 sector-focused professionals to anticipate trends, identify their implications and help our clients create competitive advantage. We can help you navigate your way forward and achieve sustainable success in the new health-outcomes-driven ecosystem.




Contact us

Lara Iob    Lara Iob 
Montreal
Life Sciences
514 879 6514
 

Connect with us

EY - Health Care Advisory Services

Health Care Advisory Services

Driving sustainable excellence in health care.

EY Life Sciences: Building a better working world

EY Life Sciences: Building a better working world

Empowered patients are demanding more. Big data and supply chains offer new challenges. EY has the vision to help solve the industry's most pressing issues.